HRT Financial’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-318,180
Closed -$1.91M 5022
2026
Q1
$1.91M Buy
+318,180
New +$2.39M ﹤0.01% 1650
2025
Q2
Sell
-1,313,992
Closed -$19.6M 3288
2025
Q1
$19.6M Buy
+1,313,992
New +$20.2M 0.12% 112
2024
Q4
Sell
-91,109
Closed -$1.74M 2999
2024
Q3
$1.74M Buy
+91,109
New +$1.89M 0.01% 940
2024
Q2
Sell
-46,347
Closed -$871K 2844
2024
Q1
$871K Sell
46,347
-15,240
-25% -$262K 0.01% 952
2023
Q4
$888K Buy
61,587
+9,156
+17% +$125K 0.01% 1049
2023
Q3
$910K Buy
+52,431
New +$1.09M 0.01% 1035
2022
Q4
Sell
-223,490
Closed -$5.23M 2941
2022
Q3
$5.23M Buy
+223,490
New +$6.75M 0.06% 285
2022
Q2
Sell
-270,385
Closed -$9.44M 3490
2022
Q1
$9.44M Buy
+270,385
New +$9.25M 0.07% 158
2021
Q4
Sell
-14,671
Closed -$481K 3811
2021
Q3
$481K Sell
14,671
-133,027
-90% -$4.26M ﹤0.01% 2031
2021
Q2
$4.47M Buy
+147,698
New +$4.86M 0.04% 337

Other funds holding OGN

HRT Financial's OGN Position: Q2 2026 in Review

HRT Financial sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 318,180 shares — an estimated $1.91M sold.

HRT Financial first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $19.6M in Q1 2025. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • HRT Financial reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 318,180 Organon & Co shares in Q2 2026, an estimated $1.91M.
  • HRT Financial first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
  • HRT Financial's Organon & Co position peaked at $19.6M in Q1 2025.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.